Ralph Snyderman - 04 Oct 2022 Form 4 Insider Report for CareDx, Inc. (CDNA)

Reporting relationship: Director
Issuer ticker: CDNA
Reported as of: 04 Oct 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Oct 2022, 17:36:58 UTC
Prior SEC filing: 06 Jul 2022
Next SEC filing: 16 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Reginald Seeto, as attorney-in-fact for Ralph Snyderman

Key filing fact

Ralph Snyderman filed Form 4 for CareDx, Inc. (CDNA) on 04 Oct 2022.

Key facts

This page summarizes Ralph Snyderman's Form 4 filing for CareDx, Inc. (CDNA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Oct 2022, 17:36.

Change

Previous filing in this sequence was filed on 06 Jul 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDNA transaction

Common Stock

Award

Transaction value: $0
Shares: +775
Change %: +1.4%
Price: $0.000000
Shares after: 58,177
Date: 04 Oct 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.